HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 18-SEP-14 4RDB TITLE CRYSTAL STRUCTURE OF AN IMMUNOREACTIVE 32 KDA ANTIGEN PG49 (PG_0181) TITLE 2 FROM PORPHYROMONAS GINGIVALIS W83 AT 1.45 A RESOLUTION (PSI COMMUNITY TITLE 3 TARGET, NAKAYAMA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOREACTIVE 32 KDA ANTIGEN PG49; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PORPHYROMONAS GINGIVALIS; SOURCE 3 ORGANISM_TAXID: 242619; SOURCE 4 STRAIN: W83; SOURCE 5 GENE: PG_0181; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PB1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PUTATIVE CELL ADHESION PROTEIN, PF16249 FAMILY, DUF4906, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 22-APR-20 4RDB 1 JRNL LINK REVDAT 3 24-JAN-18 4RDB 1 JRNL REVDAT 2 22-NOV-17 4RDB 1 REMARK REVDAT 1 03-DEC-14 4RDB 0 JRNL AUTH Q.XU,M.SHOJI,S.SHIBATA,M.NAITO,K.SATO,M.A.ELSLIGER, JRNL AUTH 2 J.C.GRANT,H.L.AXELROD,H.J.CHIU,C.L.FARR,L.JAROSZEWSKI, JRNL AUTH 3 M.W.KNUTH,A.M.DEACON,A.GODZIK,S.A.LESLEY,M.A.CURTIS, JRNL AUTH 4 K.NAKAYAMA,I.A.WILSON JRNL TITL A DISTINCT TYPE OF PILUS FROM THE HUMAN MICROBIOME. JRNL REF CELL V. 165 690 2016 JRNL REFN ISSN 1097-4172 JRNL PMID 27062925 JRNL DOI 10.1016/J.CELL.2016.03.016 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 55846 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.119 REMARK 3 R VALUE (WORKING SET) : 0.117 REMARK 3 FREE R VALUE : 0.157 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2833 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3826 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.02 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE SET COUNT : 194 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2383 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : 0.39000 REMARK 3 B33 (A**2) : -0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.058 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.055 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.038 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.332 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.981 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.971 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2593 ; 0.013 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2519 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3529 ; 1.605 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5818 ; 0.779 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 337 ; 6.415 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 114 ;34.035 ;24.561 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 422 ;10.897 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.957 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 403 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2906 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 562 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1256 ; 1.729 ; 0.989 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1254 ; 1.728 ; 0.988 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1575 ; 1.975 ; 1.488 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5112 ;11.703 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 133 ;29.418 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 5361 ; 9.542 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. EDO AND ACETONE (ACN) MODELED WAS PRESENT IN REMARK 3 CRYSTALLIZATION/CRYO CONDITIONS. REMARK 4 REMARK 4 4RDB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000087203. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184,0.9791 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : RHODIUM-COATED VERTICAL AND REMARK 200 HORIZONTAL FOCUSING MIRRORS; REMARK 200 LIQUID-NITROGEN COOLED DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE JANUARY 10, 2014 REMARK 200 BUILT=20140307 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55908 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 43.411 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.71400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.17M SODIUM ACETATE, 15.0% GLYCEROL, REMARK 280 28.5% POLYETHYLENE GLYCOL 4000, 4.0% ACETONE, 0.1M TRIS PH 9.0, REMARK 280 NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.81800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.32250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.41050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.32250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.81800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.41050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUGGESTS THE ASSIGNMENT OF A REMARK 300 MONOMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 48 REMARK 465 VAL A 49 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 129 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 179 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 412 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACN A 414 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-425089 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 30-333 OF THE TARGET REMARK 999 SEQUENCE. DBREF 4RDB A 30 333 UNP Q7MXK0 Q7MXK0_PORGI 30 333 SEQADV 4RDB GLY A 0 UNP Q7MXK0 LEADER SEQUENCE SEQRES 1 A 305 GLY ASP ARG SER ILE GLU ILE SER ILE ARG VAL ASP ASP SEQRES 2 A 305 PHE THR LYS THR GLY GLU ALA VAL ARG TYR GLU ARG ASN SEQRES 3 A 305 GLN GLY SER ALA ALA GLU ARG LEU ILE THR ASN LEU TYR SEQRES 4 A 305 LEU LEU LEU PHE ASP GLN SER GLY ALA ASN PRO ALA LYS SEQRES 5 A 305 TYR TYR ILE THR GLY ASN THR PHE THR GLY GLY THR TRP SEQRES 6 A 305 LEU PRO ASP ASP MSE LYS VAL LYS LEU ASP MSE THR GLN SEQRES 7 A 305 SER GLU ALA GLY GLU ARG LYS VAL TYR VAL VAL ALA ASN SEQRES 8 A 305 VAL ASP ASN ALA VAL LYS THR ALA LEU ASP ALA VAL ALA SEQRES 9 A 305 ASN GLU SER ASP LEU GLN THR VAL LYS ARG THR THR ALA SEQRES 10 A 305 MSE PRO TRP SER THR ASP ILE ALA SER PRO PHE LEU MSE SEQRES 11 A 305 SER GLY ASN LYS THR HIS ASP PHE LEU ALA ASN ARG LEU SEQRES 12 A 305 LEU ASP ASN VAL PRO LEU VAL ARG ALA ILE ALA LYS VAL SEQRES 13 A 305 GLU LEU ASN ILE SER LEU SER GLU LYS PHE GLN ILE VAL SEQRES 14 A 305 PRO ILE ILE VAL ASN GLY SER LEU SER GLU PHE LYS PHE SEQRES 15 A 305 ARG TYR VAL ASN PHE ASP LYS GLU THR TYR VAL VAL LYS SEQRES 16 A 305 PRO THR THR LYS PRO ASP ASN LEU ILE SER SER ALA ASN SEQRES 17 A 305 GLY VAL TRP PRO GLN ILE THR ASP TRP THR VAL TRP GLY SEQRES 18 A 305 ALA SER LEU ASN THR SER PRO ALA PRO ASP ALA GLY THR SEQRES 19 A 305 GLY TYR THR LEU ASP ALA ASN GLY LYS VAL THR ALA LEU SEQRES 20 A 305 ARG ILE VAL THR TYR LEU ASN GLU ARG ASP SER LYS GLY SEQRES 21 A 305 ALA THR VAL GLU VAL ALA LEU PRO ARG VAL ASP ASP GLY SEQRES 22 A 305 THR LEU PRO PRO PRO GLU PHE GLY PRO GLU LEU TYR ARG SEQRES 23 A 305 LEU PRO LEU PRO ASP LYS ILE LEU ARG ASN HIS TRP TYR SEQRES 24 A 305 LYS TYR GLU VAL GLU ILE MODRES 4RDB MSE A 98 MET SELENOMETHIONINE MODRES 4RDB MSE A 104 MET SELENOMETHIONINE MODRES 4RDB MSE A 146 MET SELENOMETHIONINE MODRES 4RDB MSE A 158 MET SELENOMETHIONINE HET MSE A 98 13 HET MSE A 104 8 HET MSE A 146 8 HET MSE A 158 8 HET EDO A 401 4 HET EDO A 402 4 HET EDO A 403 4 HET EDO A 404 4 HET EDO A 405 4 HET EDO A 406 4 HET EDO A 407 4 HET EDO A 408 4 HET EDO A 409 4 HET EDO A 410 4 HET EDO A 411 4 HET EDO A 412 4 HET EDO A 413 4 HET ACN A 414 4 HETNAM MSE SELENOMETHIONINE HETNAM EDO 1,2-ETHANEDIOL HETNAM ACN ACETONE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 2 EDO 13(C2 H6 O2) FORMUL 15 ACN C3 H6 O FORMUL 16 HOH *420(H2 O) HELIX 1 1 SER A 57 LEU A 62 1 6 HELIX 2 2 PRO A 95 ASP A 97 5 3 HELIX 3 3 GLN A 106 GLY A 110 1 5 HELIX 4 4 ASP A 121 VAL A 131 1 11 HELIX 5 5 ASN A 133 THR A 139 5 7 HELIX 6 6 GLU A 192 GLN A 195 5 4 HELIX 7 7 ALA A 250 THR A 254 5 5 HELIX 8 8 PRO A 304 PHE A 308 5 5 SHEET 1 A 9 ALA A 79 ILE A 83 0 SHEET 2 A 9 LEU A 66 PHE A 71 -1 N LEU A 66 O ILE A 83 SHEET 3 A 9 GLU A 111 ALA A 118 -1 O TYR A 115 N LEU A 69 SHEET 4 A 9 MSE A 158 ASP A 165 -1 O HIS A 164 N ARG A 112 SHEET 5 A 9 LEU A 171 ARG A 179 -1 O VAL A 178 N SER A 159 SHEET 6 A 9 SER A 32 VAL A 39 1 N ARG A 38 O LEU A 177 SHEET 7 A 9 LYS A 99 THR A 105 -1 O VAL A 100 N ILE A 35 SHEET 8 A 9 GLY A 91 LEU A 94 -1 N THR A 92 O LYS A 101 SHEET 9 A 9 THR A 87 PHE A 88 -1 N PHE A 88 O GLY A 91 SHEET 1 B 6 GLU A 52 ASN A 54 0 SHEET 2 B 6 PHE A 42 THR A 45 -1 N LYS A 44 O GLU A 52 SHEET 3 B 6 HIS A 325 ILE A 333 1 O TRP A 326 N THR A 43 SHEET 4 B 6 ILE A 181 LEU A 190 1 N GLU A 185 O TYR A 327 SHEET 5 B 6 VAL A 272 ASN A 282 -1 O LEU A 281 N ALA A 182 SHEET 6 B 6 GLY A 261 LEU A 266 -1 N THR A 265 O THR A 273 SHEET 1 C 2 LYS A 141 THR A 143 0 SHEET 2 C 2 GLU A 218 TYR A 220 -1 O THR A 219 N ARG A 142 SHEET 1 D 3 ILE A 200 VAL A 201 0 SHEET 2 D 3 SER A 204 VAL A 213 -1 O SER A 204 N VAL A 201 SHEET 3 D 3 THR A 246 TRP A 248 -1 O THR A 246 N PHE A 210 SHEET 1 E 4 ILE A 200 VAL A 201 0 SHEET 2 E 4 SER A 204 VAL A 213 -1 O SER A 204 N VAL A 201 SHEET 3 E 4 THR A 290 LEU A 295 -1 O ALA A 294 N LYS A 209 SHEET 4 E 4 GLU A 311 PRO A 316 -1 O LEU A 315 N VAL A 291 SHEET 1 F 2 PHE A 215 ASP A 216 0 SHEET 2 F 2 LEU A 231 ILE A 232 -1 O ILE A 232 N PHE A 215 LINK C ASP A 97 N MSE A 98 1555 1555 1.33 LINK C MSE A 98 N LYS A 99 1555 1555 1.33 LINK C ASP A 103 N MSE A 104 1555 1555 1.33 LINK C MSE A 104 N THR A 105 1555 1555 1.34 LINK C ALA A 145 N MSE A 146 1555 1555 1.33 LINK C MSE A 146 N PRO A 147 1555 1555 1.35 LINK C LEU A 157 N MSE A 158 1555 1555 1.34 LINK C MSE A 158 N SER A 159 1555 1555 1.34 CISPEP 1 SER A 149 THR A 150 0 7.26 CISPEP 2 SER A 154 PRO A 155 0 0.79 CISPEP 3 ASP A 173 ASN A 174 0 9.24 CISPEP 4 TRP A 239 PRO A 240 0 7.46 CISPEP 5 SER A 255 PRO A 256 0 -7.37 SITE 1 AC1 6 TRP A 148 PHE A 210 THR A 246 ACN A 414 SITE 2 AC1 6 HOH A 634 HOH A 790 SITE 1 AC2 4 ASN A 77 MSE A 104 GLU A 108 ARG A 112 SITE 1 AC3 6 TYR A 81 TYR A 82 THR A 89 EDO A 408 SITE 2 AC3 6 EDO A 409 HOH A 612 SITE 1 AC4 8 PHE A 194 GLU A 311 LEU A 312 TYR A 313 SITE 2 AC4 8 ILE A 333 EDO A 412 HOH A 695 HOH A 900 SITE 1 AC5 6 SER A 36 ILE A 37 ARG A 38 MSE A 98 SITE 2 AC5 6 THR A 254 HOH A 876 SITE 1 AC6 7 ARG A 142 ASP A 151 ALA A 153 PRO A 155 SITE 2 AC6 7 HOH A 691 HOH A 736 HOH A 897 SITE 1 AC7 4 ASP A 72 GLN A 73 ALA A 109 GLU A 111 SITE 1 AC8 6 TYR A 67 LYS A 125 ASP A 129 EDO A 403 SITE 2 AC8 6 HOH A 713 HOH A 832 SITE 1 AC9 8 TYR A 82 ILE A 83 THR A 84 GLY A 85 SITE 2 AC9 8 PHE A 88 PRO A 306 EDO A 403 HOH A 737 SITE 1 BC1 6 THR A 139 LYS A 141 ILE A 199 ILE A 200 SITE 2 BC1 6 TYR A 220 HOH A 564 SITE 1 BC2 5 ARG A 31 PRO A 198 GLY A 270 HOH A 774 SITE 2 BC2 5 HOH A 891 SITE 1 BC3 6 GLN A 73 LEU A 312 TYR A 313 ARG A 314 SITE 2 BC3 6 EDO A 404 HOH A 742 SITE 1 BC4 8 ARG A 38 ASP A 40 ASP A 41 ARG A 53 SITE 2 BC4 8 PRO A 256 HOH A 598 HOH A 715 HOH A 875 SITE 1 BC5 6 SER A 149 TYR A 212 GLY A 261 VAL A 278 SITE 2 BC5 6 EDO A 401 HOH A 616 CRYST1 39.636 86.821 90.645 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025230 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011518 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011032 0.00000 MASTER 343 0 18 8 26 0 26 6 0 0 0 24 END